GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
480
c/glp1eu·posted 1 year ago by u/amira_dumitru

why does nobody talk about Apotheke

Country Cold Box ×8

why does nobody talk about Apotheke. I am not trying to be the "source?" guy. I would just like a source.

The structure that makes this board make sense, once.

Marketing authorisation for these products is granted centrally, which is why the same product exists across the union. Everything after that — whether it is reimbursed, on what criteria, at what price, in what pack size, dispensed under what margin rules — is decided nationally.

So "is it covered" has twenty-seven answers, "what does it cost" has twenty-seven answers plus within-country variation, and only "is it authorised" has one. Almost every argument on this board is two people answering different questions from different countries, both correctly.

How to compare prices across borders without misleading yourself.

Normalise the pack size first. Presentations differ between member states and a headline figure for one pack is not comparable to another. Then separate reimbursed from private prices, which are set by entirely different mechanisms. Then note the dispensing fee structure, which is nationally regulated.

When members here have done all three, the interesting finding has consistently been that variation between pharmacies within a country is often as large as the variation between countries — which makes the cross-border shopping most of these threads are really about far less attractive than it looks.

On cross-border prescriptions, since the assumption behind half these threads is wrong.

There are EU rules on the recognition of prescriptions issued in another member state, and they are conditional: the prescription has to meet requirements about its form and content, certain categories are excluded, and pharmacies retain discretion in practice.

The result is that "my prescription will be accepted anywhere in the EU" is not a safe assumption, and members here have discovered it at a counter in another country. If it matters for a trip, check before you travel with the pharmacy and with somebody qualified where you are. Nothing on this board is advice about that, and the rules are national in their application whatever the framework says.

I will update this if the picture changes rather than quietly leaving it up.

3,665 up / 3,185 down54% upvoted27 commentsid 1v8lm927 Sep 2024

27 comments

21 in this archive, depth 5

best — the order this archive was captured in

u/marit_laurent32 points·1 year ago

Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.

replysharereportpermalink
u/patient_labslip_log18 points·1 year ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink
u/throwaway_44b113 points·1 year ago

a shortage in one member state is not a shortage in all of them

This is the split the whole board depends on. Authorisation is European; payment is national.

replysharereportpermalink
u/renal_outcomes_rnephro-curious8 points·1 year ago

This is the split the whole board depends on.

Disagreeing with this bit: that criterion belongs to one member state and is being quoted as general.

replysharereportpermalink
u/gallbladder_gary5 points·1 year ago

EU-wide advice is almost always wrong somewhere

replysharereportpermalink
u/amira_dumitruOP3 points·1 year ago

Small fix — those two prices are for different pack sizes, which accounts for most of the gap.

replysharereportpermalink
u/eu_apotheke_a4 points·1 year ago

Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.

replysharereportpermalink
[deleted]3 points·1 year ago

[deleted]

replysharereportpermalink
u/eu_apotheke_a4 points·1 year ago

What pack size is that price for?

replysharereportpermalink
u/preservative_free_p19 points·1 year ago

Is the prescription from the same country as the pharmacy?

replysharereportpermalink
u/marit_laurent7 points·1 year ago

Is the prescription from the same country as the pharmacy?

preservative_free_p is right about cross-border recognition being narrower than the summaries suggest.

replysharereportpermalink
u/amira_dumitru11 points·1 year ago

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

replysharereportpermalink
u/hydration_hank8 points·1 year ago·edited

Not convinced — cross-border prescription recognition is narrower than you are describing and the exceptions matter.

replysharereportpermalink
u/amira_dumitruOP5 points·1 year ago

Not convinced — cross-border prescription recognition is narrower than you are describing and the exceptions matter.

Adding the practical step — read your own country’s published criteria. They exist and they are definitive.

replysharereportpermalink
u/ahmed_rasmussen4 points·1 year ago

Agreed — authorisation is European, reimbursement is national, and almost every confused thread here misses that split.

replysharereportpermalink
u/stablecoin_steve5 points·1 year ago

Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.

replysharereportpermalink
u/marit_mwangi2 points·1 year ago

That shortage notice was national and does not apply where the question is coming from.

replysharereportpermalink
u/no_refunds_nr2 points·1 year ago

a prescription from one member state is not automatically valid in another

replysharereportpermalink
u/amira_dumitruOP1 point·1 year ago

Correcting myself upthread: the criterion I quoted was updated for this year.

replysharereportpermalink
u/fabio_nkemelu4 points·1 year ago

Kept the prescription and the receipt for a claim, purely because a thread here told me to. Both were requested.

replysharereportpermalink
u/ingrid_correia2 points·1 year ago

Which member state?

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.